Thrombophilia testing in the era of direct oral anticoagulants
Jennifer Darlow and Holly Mould
DOI: https://doi.org/10.7861/clinmed.2020-1008
Clin Med September 2021 Jennifer Darlow
AManchester Royal Infirmary, Manchester, UK
*equal first authors
Roles: haematology registrar
Holly Mould
BUniversity of Manchester, Manchester, UK
*equal first authors
Roles: medical student
Article Tools
Thrombophilia testing in the era of direct oral anticoagulants
Jennifer Darlow, Holly Mould
Clinical Medicine Sep 2021, 21 (5) e487-e491; DOI: 10.7861/clinmed.2020-1008
Citation Manager Formats
Jump to section
- Article
- ABSTRACT
- Introduction
- Types of thrombophilia
- Who needs thrombophilia testing?
- Heritable thrombophilias
- Risk scores
- Acquired thrombophilias
- How do DOACs affect thrombophilia testing?
- DOAC effects on APS testing
- Possible solutions to the DOAC effect on thrombophilia testing
- The DOAC-StopTM
- Can we give DOACs in thrombophilia?
- Can we give DOACs in APS?
- Conclusion
- Key practice implications
- Acknowledgements
- References
- Figures & Data
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- No citing articles found.